As of 2025-06-24, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (28.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.77 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -515.4%.
The range of the Relative Valuation is (27.59) - (27.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 13.1x | 12.2x |
| Forward P/E multiples | 10.4x - 11.5x | 11.0x |
| Fair Price | (27.59) - (27.78) | (28.12) |
| Upside | -507.5% - -510.4% | -515.4% |
| Date | P/E |
| 2025-06-23 | -2.69 |
| 2025-06-20 | -2.57 |
| 2025-06-18 | -2.60 |
| 2025-06-17 | -2.57 |
| 2025-06-16 | -2.57 |
| 2025-06-13 | -2.58 |
| 2025-06-12 | -2.72 |
| 2025-06-11 | -2.75 |
| 2025-06-10 | -2.78 |
| 2025-06-09 | -2.68 |
| 2025-06-06 | -2.73 |
| 2025-06-05 | -2.50 |
| 2025-06-04 | -2.61 |
| 2025-06-03 | -2.64 |
| 2025-06-02 | -2.60 |
| 2025-05-30 | -2.61 |
| 2025-05-29 | -2.66 |
| 2025-05-28 | -2.68 |
| 2025-05-27 | -2.61 |
| 2025-05-23 | -2.64 |
| 2025-05-22 | -2.68 |
| 2025-05-21 | -2.65 |
| 2025-05-20 | -2.86 |
| 2025-05-19 | -2.78 |
| 2025-05-16 | -2.74 |
| 2025-05-15 | -2.26 |
| 2025-05-14 | -2.33 |
| 2025-05-13 | -2.43 |
| 2025-05-12 | -2.41 |
| 2025-05-09 | -2.33 |
| 2025-05-08 | -2.62 |
| 2025-05-07 | -1.96 |
| 2025-05-06 | -1.98 |
| 2025-05-05 | -2.04 |
| 2025-05-02 | -2.12 |
| 2025-05-01 | -2.03 |
| 2025-04-30 | -2.20 |
| 2025-04-29 | -2.25 |
| 2025-04-28 | -2.25 |
| 2025-04-25 | -2.26 |
| 2025-04-24 | -2.21 |
| 2025-04-23 | -2.05 |
| 2025-04-22 | -1.95 |
| 2025-04-21 | -1.87 |
| 2025-04-17 | -1.91 |
| 2025-04-16 | -1.91 |
| 2025-04-15 | -1.91 |
| 2025-04-14 | -1.89 |
| 2025-04-11 | -1.81 |
| 2025-04-10 | -1.76 |